Member State Consultations 

During the first phase of the Oslo Medicines Initiative, WHO/Europe hosted an online consultation for all 53 Member States and areas in the WHO European Region. 

The objectives of the consultation were to:

• understand perspectives on access to effective, novel, high-priced medicines, in particular the current roles and responsibilities of the public and private sectors;

• receive their feedback on the proposals for the Oslo Medicines Initiative set out in the draft scope and purpose document.

Copies of the programme, the draft scope and purpose document, and a discussion paper setting out consultation questions relating to the objectives of the Initiative are available at the links below. 

In response to the consultation questions, Member States and areas were invited to give a 5-minute intervention and to submit written statements. To ensure transparency, the written statements received and a summary report of the issues discussed will be published at the end of the first stage of consultations. 

Non-State Actor Consultations 

With the agreement of Member States, the invitation to participate in an online consultation, and the option to submit written statements, was extended to agreed non-state actors, including those from the private sector, patients’ associations, and civil society bodies.  

Two non-state actor consultations were planned for the first phase of the Initiative, one with non-governmental and philanthropic organizations, and another with the private sector.

The non-governmental and philanthropic organizations consultation took place on 26 April 2021, with the private sector consultation following on 27 April 2021.  

The objectives of the non-state actor consultations in 2021 were to:

• understand different perspectives on access to effective, novel, high-priced medicines, particularly relating to the current roles and responsibilities of the public and private sectors;

• receive input on the proposals for the Oslo Medicines Initiative set out in the draft scope and purpose and discussion documents.

In response to the consultation questions from the discussion document, non-state actors were invited to present their views and to submit written statements including the name and logo of the submitting entity. To ensure transparency, the written statements have been made public along with a summary report of the issues discussed during the consultation.